Biohit Oyj

Related Party Transaction • Aug 15, 2014

Disclosure 317111

Biohit Oyj - Company Announcement

Biohit Oyj and Eastar Pharmaceuticals LLC to sign an Acetium® lozenge distribution agreement

Biohit Oyj Biohit Oyj Stock Exchange Release August 15, 2014 at 9:30 a.m. local time (EEST) Biohit Oyj has signed a distribution agreement with Eastar Pharmaceuticals LLC. The agreement is effective immediately and Eastar Pharmaceuticals LLC gains exclusive rights for the distribution of Acetium® lozenge in China. The Acetium® lozenge is intended for smokers to bind acetaldehyde that dissolves in saliva during smoking. Acetaldehyde is the most important carcinogen in cigarette smoke. (1,2) CEO Semi Korpela, Biohit Oyj: ‘We welcome Eastar Pharmaceuticals LLC to join our distribution network. The Acetium® lozenge Chinese registration procedures and distribution channel preparations start now together with a strong partner. ‘ CEO Tony Chu, Eastar Pharmaceuticals LLC: ‘We are very excited about working with the Biohit team. Biohit's Acetium® product reduces the health risks among smokers and could be an integral part of Chinese consumers' daily lives.' On-going clinical studies with the Acetium® lozenge: Clinical intervention trial with Acetium® lozenge aimed at smoking cessation, read more at http://goo.gl/2vcvbt. References: (1) Haussmann H-J (2012) Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol 2012;25:794-810. (2) Burns DM et al (2008) Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control 2008;17:132-41. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is “Innovating for Health” - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com Eastar Pharmaceuticals LLC in brief Eastar Pharmaceuticals LLC is a US pharmaceutical investment advisory and licensing company. With its strategic partners, subsidiaries and joint venture companies, Eastar licenses and markets innovative pharmaceuticals, medical devices, diagnostics and health related products to China and ASEAN countries. www.chinaeastar.com/en/